Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)

NSE:ADVENZYMES Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	35,284	28,575	31,265	38,965	25,943	31,539
Market Cap Growth	-9.53%	-8.61%	-19.76%	50.19%	-17.74%	-18.17%
Enterprise Value	29,067	23,355	27,136	35,180	23,011	28,981
Last Close Price	315.10	254.20	273.46	336.41	220.10	266.64

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	20.92	16.94	23.85	29.23	24.56	26.37
Forward PE	20.33	16.99	18.03	26.80	18.49	21.66
PS Ratio	4.73	3.83	4.91	6.25	4.80	5.96
PB Ratio	2.10	1.70	2.13	2.84	2.02	2.77
P/TBV Ratio	2.90	2.35	3.02	4.14	3.04	4.34
P/FCF Ratio	33.75	27.33	28.77	39.34	25.37	33.49
P/OCF Ratio	22.51	18.23	21.94	27.56	18.48	25.79
PEG Ratio	1.26	1.06	1.49	1.49	1.49	1.49

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	3.90	3.13	4.26	5.64	4.26	5.47
EV/EBITDA Ratio	12.95	10.76	14.75	18.06	15.27	15.11
EV/EBIT Ratio	15.34	12.33	17.17	20.75	18.31	17.41
EV/FCF Ratio	27.80	22.34	24.97	35.52	22.50	30.77

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.02	0.02	0.03	0.04	0.03	0.03
Debt / EBITDA Ratio	0.14	0.14	0.21	0.23	0.21	0.18
Debt / FCF Ratio	0.31	0.31	0.36	0.48	0.33	0.37
Net Debt / Equity Ratio	-0.40	-0.40	-0.38	-0.36	-0.35	-0.29
Net Debt / EBITDA Ratio	-3.10	-3.10	-3.01	-2.56	-2.98	-1.75
Net Debt / FCF Ratio	-6.44	-6.44	-5.09	-5.04	-4.39	-3.57
Asset Turnover	0.43	0.43	0.40	0.42	0.40	0.44
Inventory Turnover	1.24	1.24	1.08	1.16	1.16	1.10
Quick Ratio	7.97	7.97	7.36	6.08	7.54	7.71
Current Ratio	9.78	9.78	9.14	7.61	9.31	10.00
Return on Equity (ROE)	11.02%	11.02%	9.44%	10.32%	8.57%	11.39%
Return on Assets (ROA)	6.85%	6.85%	6.26%	7.17%	5.84%	8.59%
Return on Invested Capital (ROIC)	14.34%	14.69%	12.64%	14.48%	11.34%	15.59%
Return on Capital Employed (ROCE)	10.90%	10.90%	10.40%	11.90%	9.30%	13.80%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	4.78%	5.90%	4.19%	3.42%	4.07%	3.79%
FCF Yield	2.96%	3.66%	3.48%	2.54%	3.94%	2.99%
Dividend Yield	1.70%	2.10%	1.90%	1.52%	0.45%	0.38%
Payout Ratio	34.48%	34.48%	43.50%	41.94%	10.59%	8.41%
Buyback Yield / Dilution	-0.04%	-0.04%	-0.10%	-0.06%	0.05%	0.00%
Total Shareholder Return	1.65%	2.06%	1.80%	1.46%	0.50%	0.38%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 31, 2026

Data Sources Report a data error